1. Home
  2. SAM vs DAWN Comparison

SAM vs DAWN Comparison

Compare SAM & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Beer Company Inc. (The)

SAM

Boston Beer Company Inc. (The)

HOLD

Current Price

$240.83

Market Cap

2.6B

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.45

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAM
DAWN
Founded
1984
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SAM
DAWN
Price
$240.83
$21.45
Analyst Decision
Hold
Buy
Analyst Count
10
10
Target Price
$227.44
$26.00
AVG Volume (30 Days)
115.4K
5.8M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
95.45
N/A
EPS
9.89
N/A
Revenue
$1,964,994,000.00
$158,182,000.00
Revenue This Year
$1.02
$55.03
Revenue Next Year
$1.31
$28.12
P/E Ratio
$24.29
N/A
Revenue Growth
N/A
20.60
52 Week Low
$186.72
$5.64
52 Week High
$260.00
$21.47

Technical Indicators

Market Signals
Indicator
SAM
DAWN
Relative Strength Index (RSI) 60.36 81.60
Support Level $211.05 $10.30
Resistance Level $252.33 N/A
Average True Range (ATR) 7.70 0.06
MACD 1.07 -0.32
Stochastic Oscillator 99.96 89.47

Price Performance

Historical Comparison
SAM
DAWN

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: